Manuel Zorzi

Biographic Data

ID7882120
NAMEManuel Zorzi
GIVEN NAMESManuel
FAMILY NAMEZorzi
SIGNATUREZORZI M
AFFILIATIONSRegione del Veneto
ORCID0000-0001-6025-5214
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
WORKS AS AUTHOR6
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2025
H-INDEX0

  • Healthcare costs of cutaneous melanoma according to comorbidity patterns

    Open AccessAlessandra Buja, Fortunato Cassalia et al.ARTICLEFrontiers in Public Health2025

    Background: Cutaneous malignant melanoma represents a notable public health issue, characterized by a rapidly increasing incidence, particularly among younger populations. Despite progress in early detection and treatment modalities, this rising trend exacerbates the healthcare system's burden. Limited research has been conducted on the impact of comorbidities on overall and melanoma-specific healthcare costs incurred by patients with melanoma. T…

  • Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019

    Open AccessAlessandra Buja, Giuseppe De Luca et al.ARTICLEFrontiers in Public Health2024

    Background: This observational study considers the sex-specific incidence of the most incident cancers as recorded in the population-based Veneto Regional Cancer Registry over a period of more than 30 years (1987-2019). Methods: The Veneto Regional Cancer Registry collected data for the time interval 1987-2019. Significant changes in incidence trends calculated on age-standardized incidence rates (Annual Percent Change-APC) were identified by joi…

  • Synchronous and metachronous multiple primary cancers in melanoma survivors

    Open AccessStefano Guzzinati, Alessandra Buja et al.ARTICLEFrontiers in Public Health2023

    Background: Long-term survivors of cutaneous malignant melanoma (CMM) risk subsequent malignancies due to both host-related and environmental risk factors. This retrospective population-based study differentially assesses the risk of synchronous and metachronous cancers in a cohort of CMM survivors stratified by sex. Methods: The cohort study (1999-2018) included 9,726 CMM survivors (M = 4,873, F = 4,853) recorded by the cancer registry of all 5,…

  • Estimating Overall and Cause-Specific Excess Mortality during the Covid-19 Pandemic

    Open AccessClaudio Barbiellini Amidei, Ugo Fedeli et al.ARTICLEInternational Journal of…2023

    During the COVID-19 pandemic, excess mortality has been reported worldwide, but its magnitude has varied depending on methodological differences that hinder between-study comparability. Our aim was to estimate variability attributable to different methods, focusing on specific causes of death with different pre-pandemic trends. Monthly mortality figures observed in 2020 in the Veneto Region (Italy) were compared with those forecasted using: (1) 2…

  • Impact of Wide Local Excision on Melanoma Patient Survival

    Open AccessAlessandra Buja, Massimo Rugge et al.ARTICLEFrontiers in Public Health2022

    Introduction Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data is essential to ensure better patient outcomes. Wide excision after primary tumor biopsy is a fundamental step in the therapeutic pathway for cutaneous malignant melanoma (CMM). The aim of this population-based cohort study is to assess adherence to wide local excision in a cohort of patients diagnosed with CMM and the impact of this r…

  • The Economic Impact of Rectal Cancer

    Open AccessAnna Gigli, Silvia Francisci et al.ARTICLEInternational Journal of…2021

    Costs of cancer care are increasing worldwide, and sustainability of cancer burden is critical. In this study, the economic impact of rectal cancer on the Italian healthcare system, measured as public healthcare expenditure related to investigation and treatment of rectal cancer patients is estimated. A cross-sectional cohort of 9358 rectal cancer patients is linked, on an individual basis, to claims associated to rectal cancer diagnosis and trea…